Aus der Gutachtenpraxis: Stimmstörungen nach COVID ohne Intubation oder Tracheotomie – Fakt oder Fiktion?

Wolfgang Angerstein

doi:10.1055/a-2308-8400

Laryngo-Rhino-Otologie, Table of Contents

Laryngorhinootologie 2024; 103(07): 525-528
DOI: 10.1055/a-2308-8400

Gutachten und Recht

Aus der Gutachtenpraxis: Stimmstörungen nach COVID ohne Intubation oder Tracheotomie – Fakt oder Fiktion? [*]

From the Expert’s Office: Voice disorders after COVID without intubation or tracheostomy – fact or fiction?

Authors

Wolfgang Angerstein

Abstract

Full Text

References

Literatur
1 Koczulla AR, Ankermann T, Behrends U. et al. S1-Leitlinie Long-/Post-COVID. Pneumologie 2022; 76: 855-907
2 Flatau TS. Die funktionelle Stimmschwäche (Phonasthenie) der Sänger, Sprecher und Kommandorufer. Charlottenburg: Bürkner 1906.
3 Shahpasand S, Olthoff A, Beutner D. Dysphonie als Post-Covid-Syndrom?. Laryngo-Rhino-Otologie 2022; 101: 147
4 Lechien JR, Chiesa-Estomba CM, Cabaraux P. et al. Features of mild-to-moderate COVID-19 patients with dysphonia. J Voice 2022; 36: 249-255
5 Lin CW, Wang YH, Li YE. et al. COVID-related dysphonia and persistent Long-COVID voice sequelae: A systematic review and meta-analysis. Am J Otolaryngol 2023; 44: 103950
6 Lladós G, Massanella M, Coll-Fernández R. et al. Vagus nerve dysfunction in the Post-COVID-19 condition: A pilot cross-sectional study. Clin Microbiol Infect 2024; 30: 515-521
7 Al-Ani RM, Rashid RA. Prevalence of dysphonia due to COVID-19 at Salahaddin General Hospital, Tikrit City, Iraq. Am J Otolaryngol 2021; 42: 103157
8 Azzam AAA, Samy A, Sefein I. et al. Vocal disorders in patients with COVID 19 in Egypt. Indian J Otolaryngol Head Neck Surg 2022; 74: 3420-3426
9 Farr E, Wolfe AR, Deshmukh S. et al. Diaphragm dysfunction in severe COVID-19 as determined by neuromuscular ultrasound. Ann Clin Transl Neurol 2021; 8: 1745-1749
10 Spiesshoefer J, Friedrich J, Regmi B. et al. Diaphragm dysfunction as a potential determinant of dyspnea on exertion in patients 1 year after COVID-19-related ARDS. Respir Res 2022; 23: 187
11 Papadopoulou M, Bakola E, Papapostolou A. et al. Autonomic dysfunction entwined with post-COVID but absent in non-post-COVID patients: A neurophysiological and neurosonology study. Ther Adv Neurol Disord 2023; 16: 1-5
12 Papadopoulou M, Bakola E, Papapostolou A. et al. Autonomic dysfunction in Long-COVID syndrome: A neurophysiological and neurosonology study. J Neurol 2022; 269: 4611-4612
13 Woo MS, Shafiq M, Fitzek A. et al. Vagus nerve inflammation contributes to dysautonomia in COVID-19. Acta Neuropathol 2023; 146: 387-394
14 Wong AC, Devason AS, Umana IC. et al. Serotonin reduction in post-acute sequelae of viral infection. Cell 2023; 186: 4851-4867
15 Offord C. Low serotonin levels might explain some Long Covid symptoms, study proposes. Im Internet: (16.10.2023); Zugriff am 10.04.2024 https://www.science.org/content/article/low-serotonin-levels-might-explain-some-long-covid-symptoms-study-proposes
16 Jeleniewska J, Niebudek-Bogusz E, Malinowski J. et al. Isolated severe dysphonia as a presentation of Post-COVID-19 syndrome. Diagnostics 2022; 12: 1839
17 Tornero C, Pastor E, Garzando MDM. et al. Non-invasive vagus nerve stimulation for COVID-19: Results from a randomized controlled trial (SAVIOR I). Front Neurol 2022; 13: 820864
18 Badran BW, Huffman SM, Dancy M. et al. A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricular Vagus Nerve Stimulation (taVNS) to manage Long COVID symptoms. Bioelectron Med 2022; 8: 13